The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU [clinicaltrials:NCT00000654]
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU [clinicaltrials:NCT00000654]
Bio2RDF identifier
NCT00000654
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00000654
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To determine the tolera ...... all the herpes group viruses.
brief title [clinicaltrials_vocabulary:brief-title]
The Tolerance of HIV-Infected ...... fections to Oral Doses of FIAU
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
1993-02-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The pyrimidine nucleosi ...... ours of any laboratory tests.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
AIDS-Related Opportunistic Infections
Antiviral Agents
Drug Evaluation
Hepatitis B
Herpesviridae Infections
Pyrimidine Nucleosides
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-12-17T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00000654
official title [clinicaltrials_vocabulary:official-title]
The Tolerance of HIV-Infected ...... fections to Oral Doses of FIAU
org study id [clinicaltrials_vocabulary:org-study-id]
ACTG 122 FIAU
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
R90-001-01, 02, 03, 04
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-12-01T00:00:00Z
identifier
clinicaltrials:NCT00000654
title
The Tolerance of HIV-Infected ...... fections to Oral Doses of FIAU
@en
type
label
The Tolerance of HIV-Infected ...... U [clinicaltrials:NCT00000654]
@en